Published in AIDS Weekly, February 6th, 2006
"Analyses were based on a cohort of 55 HIV infected patients whose treatment was changed due to therapy failure. Vital load, CD4+ and CD8+ cell Counts were determined before therapy and after 8 weeks and 16-32 weeks, respectively," scientists in Germany report.
According to N.H. Brockmeyer and colleagues at Ruhr University of Bochum, "GNB3 genotyping was performed using pyrosequencing. Chemotaxis of purified CD4+ cello was quantified in a Boyden chamber using stromal cell-derived factor 1 alpha (SDF-1 alpha) as a stimulus.
"Age gender, route of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.